Skip to content
value.today

Quest Diagnostics Incorporated: insider trading

1,858 trades by 44 directors, officers and 10% owners since 2010, from their SEC Form 4 and 5 filings.

Bought, 12 months
$0
0 purchases by 0 insiders
Sold, 12 months
$47.4 M
41 sales by 9 insiders
Bought, 3 months
$0
0 purchases
Sold, 3 months
$19.8 M
17 sales

Insider buying and selling by month

Open-market purchases and sales by value, last three years.

-$14.0 M$0Feb 2024: bought $0 (0 trades), sold $2.1 M (6 trades)Feb 24Apr 2024: bought $0 (0 trades), sold $246 K (1 trades)Jul 2024: bought $0 (0 trades), sold $60 K (1 trades)Aug 2024: bought $0 (0 trades), sold $5.3 M (2 trades)AugOct 2024: bought $0 (0 trades), sold $279 K (1 trades)Nov 2024: bought $0 (0 trades), sold $14.0 M (10 trades)Feb 2025: bought $0 (0 trades), sold $907 K (8 trades)FebMar 2025: bought $0 (0 trades), sold $2.0 M (4 trades)Apr 2025: bought $0 (0 trades), sold $7.0 M (16 trades)May 2025: bought $0 (0 trades), sold $307 K (2 trades)MayJul 2025: bought $0 (0 trades), sold $1.8 M (3 trades)Aug 2025: bought $0 (0 trades), sold $2.5 M (5 trades)Sep 2025: bought $0 (0 trades), sold $5.4 M (4 trades)SepOct 2025: bought $0 (0 trades), sold $270 K (1 trades)Nov 2025: bought $0 (0 trades), sold $12.3 M (5 trades)Feb 2026: bought $0 (0 trades), sold $7.3 M (9 trades)FebMar 2026: bought $0 (0 trades), sold $5.5 M (8 trades)Jun 2026: bought $0 (0 trades), sold $3.6 M (2 trades)Jul 2026: bought $0 (0 trades), sold $376 K (1 trades)JulAug 2026: bought $0 (0 trades), sold $5.5 M (3 trades)Sep 2026: bought $0 (0 trades), sold $2.4 M (1 trades)Oct 2026: bought $0 (0 trades), sold $292 K (1 trades)OctNov 2026: bought $0 (0 trades), sold $11.6 M (12 trades)
Bought (open market)Sold (open market)Hover a month for the totals

Insiders (44)

Each insider's latest direct holding and their open-market trades of the last 12 months, most recent first.

Quest Diagnostics Incorporated insiders
InsiderShares owned directlyBought, 12 mSold, 12 mLatest trade
Michael J. DeppeSVP, Corp. Controller & CAO35,203—$3.1 M
Patrick PlewmanSVP for Diagnostic Services14,684—$5.0 M
Catherine T. DohertyExecutive Vice President71,949—$12.4 M
Mark E. DelaneySVP & Chief Commercial Officer12,975—$376 K
Subu RamachandranSVP, Regional Businesses2,832——
Gary M. PfeifferDirector29,802—$292 K
Karthik KuppusamySVP, Clinical Solutions13,619—$2.2 M
Robert B. CarterDirector3,874——
Sam SamadExecutive Vice President & CFO33,568——
Timothy L. MainDirector22,478——
Vicky B. GreggDirector18,449—$240 K
Wright Lassiter IIIDirector10,329——
J. E. DavisCEO and President, Director122,423—$17.1 M
Michael E. PrevoznikSVP & General Counsel36,557—$6.6 M
Denise M. MorrisonDirector11,929——
Luis DiazDirector5,196——
Timothy C. WentworthDirector1,358——
Timothy M. RingDirector31,140——
Tracey DoiDirector7,748——
Mark A. GardnerSVP of Molecular Gen & Oncol4,673——
Gail R. WilenskyDirector20,506——
Stephen H. RusckowskiDirector389,597——
Manner Carrie EglintonSVP, Advanced Diagnostics48,391——
Mark GuinanExecutive Vice President & CFO98,981——
Helen TorleyDirector6,260——
Manuel O. MendezSVP & Chief Commercial Officer29,045——
Daniel StanzioneDirector28,349——
Everett CunninghamSVP, Commercial38,311——
Robert A. KlugVP, Corporate Controller6,261——
Jenne K. BritellDirector17,660——
Jeffrey M. LeidenDirector6,000——
Jon R. CohenSVP & Group Exec. Diag. Sol.31,757——
John B. ZieglerDirector16,557——
John C. BaldwinDirector12,949——
Thomas F. BongiornoVP and Corporate Controller11,837——
John B. HaydonSVP, Operations19,890——
William F. BuehlerDirector26,225——
Kathy OrdonezSVP, Diagnostic Solutions9,569——
Robert HagemannSVP & Chief Financial Officer126,722——
Surya N. MohapatraChairman, President & CEO, Director243,713——
Joan Elizabeth MillerSVP-Oncology & Neurology Srvcs89,232——
Wayne R. SimmonsVice President, Operations47,150——
Glaxosmithkline PLCDirector, 10% owner———
Rosanne HaggertyDirector9,334——

Trades#

Quest Diagnostics Incorporated: insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Mark GuinanSenior Vice President & CFOBuy+4,000$55.51$222 K44,222Form 4
filed Timothy L. MainDirectorBuy+2,400$50.70$122 K3,058Form 4
filed Timothy L. MainDirectorBuy+2,600$50.71$132 K5,658Form 4
filed Stephen H. RusckowskiPresident and CEO, DirectorBuy+5,000$59.34$297 K68,034Form 4
filed Stephen H. RusckowskiPresident and CEO, DirectorBuy+20,000$56.89$1.1 M63,034Form 4

Source: SEC Forms 4 and 5. A trade under a 10b5-1 plan was scheduled in advance. For information only; not investment advice